Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4112 | 1769 | 53.8 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1520 | 6929 | LITHIUM//GLYCOGEN SYNTHASE KINASE 3//GSK 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLYCOGEN SYNTHASE KINASE 3 | Author keyword | 92 | 40% | 10% | 177 |
2 | GSK 3 | Author keyword | 58 | 29% | 10% | 173 |
3 | GLYCOGEN SYNTHASE KINASE 3 BETA | Author keyword | 50 | 29% | 8% | 143 |
4 | GSK 3 BETA | Author keyword | 41 | 20% | 10% | 184 |
5 | TDZD 8 | Author keyword | 32 | 88% | 1% | 15 |
6 | GSK 3 INHIBITORS | Author keyword | 30 | 84% | 1% | 16 |
7 | GSK 3 BETA INHIBITORS | Author keyword | 15 | 88% | 0% | 7 |
8 | GLYCOGEN SYNTHASE KINASE GSK 3 | Author keyword | 12 | 86% | 0% | 6 |
9 | GLYCOGEN SYNTHASE KINASE | Author keyword | 11 | 28% | 2% | 33 |
10 | GSK 3 BETA INHIBITOR | Author keyword | 11 | 78% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLYCOGEN SYNTHASE KINASE 3 | 92 | 40% | 10% | 177 | Search GLYCOGEN+SYNTHASE+KINASE+3 | Search GLYCOGEN+SYNTHASE+KINASE+3 |
2 | GSK 3 | 58 | 29% | 10% | 173 | Search GSK+3 | Search GSK+3 |
3 | GLYCOGEN SYNTHASE KINASE 3 BETA | 50 | 29% | 8% | 143 | Search GLYCOGEN+SYNTHASE+KINASE+3+BETA | Search GLYCOGEN+SYNTHASE+KINASE+3+BETA |
4 | GSK 3 BETA | 41 | 20% | 10% | 184 | Search GSK+3+BETA | Search GSK+3+BETA |
5 | TDZD 8 | 32 | 88% | 1% | 15 | Search TDZD+8 | Search TDZD+8 |
6 | GSK 3 INHIBITORS | 30 | 84% | 1% | 16 | Search GSK+3+INHIBITORS | Search GSK+3+INHIBITORS |
7 | GSK 3 BETA INHIBITORS | 15 | 88% | 0% | 7 | Search GSK+3+BETA+INHIBITORS | Search GSK+3+BETA+INHIBITORS |
8 | GLYCOGEN SYNTHASE KINASE GSK 3 | 12 | 86% | 0% | 6 | Search GLYCOGEN+SYNTHASE+KINASE+GSK+3 | Search GLYCOGEN+SYNTHASE+KINASE+GSK+3 |
9 | GLYCOGEN SYNTHASE KINASE | 11 | 28% | 2% | 33 | Search GLYCOGEN+SYNTHASE+KINASE | Search GLYCOGEN+SYNTHASE+KINASE |
10 | GSK 3 BETA INHIBITOR | 11 | 78% | 0% | 7 | Search GSK+3+BETA+INHIBITOR | Search GSK+3+BETA+INHIBITOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLYCOGEN SYNTHASE KINASE 3 | 90 | 15% | 31% | 542 |
2 | KINASE 3 BETA | 81 | 53% | 6% | 107 |
3 | GSK 3 | 76 | 50% | 6% | 110 |
4 | GSK 3 BETA | 51 | 37% | 6% | 112 |
5 | GLYCOGEN SYNTHASE KINASE 3 BETA | 48 | 16% | 16% | 278 |
6 | 3 BETA | 32 | 63% | 2% | 32 |
7 | GSK 3 INHIBITORS | 31 | 62% | 2% | 32 |
8 | REDUCES TAU PHOSPHORYLATION | 22 | 60% | 1% | 24 |
9 | GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS | 15 | 88% | 0% | 7 |
10 | STIMULATED GLUCOSE METABOLISM | 14 | 60% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases | 2015 | 4 | 292 | 57% |
The glamour and gloom of glycogen synthase kinase-3 | 2004 | 864 | 70 | 69% |
Glycogen synthase kinase 3: more than a namesake | 2009 | 187 | 132 | 64% |
Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments | 2014 | 19 | 193 | 44% |
GSK-3: tricks of the trade for a multi-tasking kinase | 2003 | 1114 | 153 | 39% |
Glycogen synthase kinase 3 beta (GSK3 beta) in tumorigenesis and cancer chemotherapy | 2009 | 142 | 54 | 63% |
GSK-3 beta, a pivotal kinase in Alzheimer disease | 2014 | 15 | 162 | 42% |
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation? | 2010 | 98 | 178 | 58% |
Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3) | 2010 | 106 | 86 | 50% |
Akt/GSK3 Signaling in the Action of Psychotropic Drugs | 2009 | 206 | 122 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PSYCHIAT BEHAV NEUROBIOL | 10 | 15% | 3.5% | 62 |
2 | MOL NEUROBIOL SECT | 9 | 22% | 2.0% | 36 |
3 | EXPT MED NEPHROL CRIT CARE MED | 8 | 100% | 0.3% | 5 |
4 | SYDNEY CORD MARROW TRANSPLANT IL | 7 | 67% | 0.3% | 6 |
5 | SPARKS 1057 | 6 | 41% | 0.6% | 11 |
6 | NEUROSIGNALLING GRP | 4 | 75% | 0.2% | 3 |
7 | SPARKS | 4 | 44% | 0.4% | 7 |
8 | STRUCT DIRECTED MOL DESIGN | 2 | 67% | 0.1% | 2 |
9 | MOL DESIGN NUTR ENGN NINGBO CITY | 2 | 26% | 0.4% | 7 |
10 | MOL PATHOPHYSIOL MOOD ANXIETY DISORDERS PRO | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000089798 | INOSITOL MONOPHOSPHATASE//INOSITOL//INOSITOL DEPLETION |
2 | 0.0000078648 | ENDOCRINE SURG S//ACHAETE SCUTE COMPLEX LIKE 1//CLIN SCI H4 750 |
3 | 0.0000078101 | ROR2//ROBINOW SYNDROME//WNT5A |
4 | 0.0000070117 | BETA CATENIN//AXIN//WNT |
5 | 0.0000069863 | TAU//PAIRED HELICAL FILAMENTS//TAU PROTEIN |
6 | 0.0000068950 | LITHIUM RESISTANCE//4C4//BLOOD LITHIUM |
7 | 0.0000048367 | INDIRUBIN//TRYPTANTHRIN//ISATIS TINCTORIA |
8 | 0.0000045631 | COLLAPSIN RESPONSE MEDIATOR PROTEIN//CRMP2//CRMP 2 |
9 | 0.0000044580 | ADRENAL DELTA5 3 BETA HSD//REPROD ENDOCRINE PHYSIOL//BIPOLARS |
10 | 0.0000044502 | PROTEIN PHOSPHATASE 1//INHIBITOR 2//GLYCOGEN SYNTHASE |